Preventing phosphorylation of eIF4E in BRAFV600; PTEN KO transgenic mouse models also results in the increased expression of MART-1 and gp100 by tumor cells and their recognition and eradication by CD8+ T cells (68). This evidence concerns the gene CD8A and neoplasm.